ICS, albuterol increased FEV1 in asthma patients – Healio

ICS, albuterol increased FEV1 in asthma patients
Healio
Researchers from the University of Miami Miller School of Medicine conducted a double blind study on 15 adult nonsmokers with asthma to analyze the change in FEV1 when patients inhaled a dose of the ICS mometasone or placebo simultaneously with or …

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.